Loading...

By Oswaldo Bernal - Mon, 11/03/2025 - 08:30

GenAI is transforming the biopharmaceutical sector by accelerating scientific discovery while improving patient care, writes Oswaldo Bernal Carmona.

Partnership Content

https://mexicobusiness.news/tag/bristol-myers-squibb-mexico

More Health

By Oswaldo Bernal - Mon, 07/21/2025 - 07:30

In the pharma industry, adherence to codes like CETIFARMA builds trust, enhances business, and ensures patient well-being, writes Oswaldo Bernal.

By Santiago Fuentes - Mon, 04/28/2025 - 08:30

Next-gen SOCs turn cybersecurity into a business strategy: AI-powered, scalable, and critical for digital resilience, writes Santiago Fuentes.

By Oswaldo Bernal - Mon, 04/28/2025 - 08:00

Clinical research fuels medical progress, and Mexico’s reforms could make it a global leader in innovation and patient access - Oswaldo Bernal.

By Oswaldo Bernal - Mon, 02/10/2025 - 08:30

Oswaldo Bernal examines the importance of ESG criteria in the pharma industry, emphasizing that they are a strategic necessity for long-term success.

By Oswaldo Bernal - Tue, 10/15/2024 - 16:00

Patient Centricity encourages collaboration among healthcare stakeholders to direct efforts and improving patient outcomes - Oswaldo Bernal.

By Sofía Garduño - Thu, 07/25/2024 - 10:00

This week, YouTube Health reported an increase in viewership, bird flu risks rise, and the Mexican Senate reviews a neurorights bill.

By Oswaldo Bernal - Mon, 07/08/2024 - 08:00

AI is no longer a futuristic concept but a catalyst that benefits health sector players, from government to pharma, writes Oswaldo Bernal.